Krystal Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. 

CEO
Krish S. Krishnan
CEOKrish S. Krishnan
Employees
275
Employees275
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2016
Founded2016
Employees
275
Employees275

KRYS Key Statistics

Market cap
4.13B
Market cap4.13B
Price-Earnings ratio
34.46
Price-Earnings ratio34.46
Dividend yield
Dividend yield
Average volume
424.78K
Average volume424.78K
High today
$143.09
High today$143.09
Low today
$140.70
Low today$140.70
Open price
$141.95
Open price$141.95
Volume
118.02K
Volume118.02K
52 Week high
$219.34
52 Week high$219.34
52 Week low
$122.80
52 Week low$122.80

KRYS News

Simply Wall St 13h
Krystal Biotech shareholder returns have been strong, earning 249% in 5 years

While Krystal Biotech, Inc. ( ) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 16%...

Krystal Biotech shareholder returns have been strong, earning 249% in 5 years
TipRanks 5d
Krystal Biotech initiated with a Buy at Clear Street

Clear Street analyst Bill Maughan initiated coverage of Krystal Biotech (KRYS) with a Buy rating and $190 price target Krystal’s first commercial product, Vyjuv...

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.